About the Company
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
18607
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SYNH News
Syneos Health (SYNH) Tops Q1 Earnings, Announces Merger Plan
Syneos Health Inc. SYNH reported first-quarter 2023 adjusted earnings per share (EPS) of 75 cents, which exceeded the Zacks Consensus Estimate by 11.9%.However, the metric declined 25.7% from the ...
Syneos Health Close To Being Acquired For $7B - Elliott, Patient Square and Veritas Investment Consortium Lead Deal
A group of investors, including Elliott Investment Management, Patient Square Capital, and Veritas Capital, is close to acquiring Syneos Health Inc (NASDAQ: SYNH) for more than $7 billion ...
Syneos Health
Addressing what’s on the minds of pharma stakeholders. The Healthcare Marketers Trend Survey shows that, as far as channel usage goes, more growth occurred in newer tactics like non-linear video and ...
Syneos Health (NASDAQ: SYNH)
Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers ...
A conversation with the Value & Access team at Syneos Health
Syneos Health Value & Access exists to help pharma brands confidently navigate this shifting market landscape. At a recent roundtable, Kara Giannecchini, senior director of Haymarket Studio, Custom ...
How Syneos Health and VBI Vaccines delivered a new kind of partnership model
Finding the right partner is not always a smooth process, but as Lee Taurman, executive vice president, global head of full-service commercial, Syneos Health, and Jeff Baxter, president and CEO ...
Civitas Resources, Inc. (CIVI)
S&P SmallCap 600 constituent Civitas Resources Inc. (NYSE: CIVI) will replace Syneos Health Inc. (NASD: SYNH) in the S&P MidCap 400, and Hayward Holdings Inc. (NYSE: HAYW) will replace Civitas ...
HLTH Cue Health Inc.
Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality ...
Syneos Health®
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization ...
Loading the latest forecasts...